According to a study published in the journal Nature Medicine, age-related cognitive decline in humans is linked to the dysfunction of oligodendrocytes, the brain cells responsible for forming myelin. Researchers from the University of Edinburgh and the UK Dementia Research Institute analyzed brain tissue from participants in the Lothian Birth Cohort 1936 to track how supportive brain cells alter nerve fiber health over time.
Oligodendrocyte Dysfunction and White Matter Changes in the Brain
The research team utilized postmortem brain tissue analysis alongside lifelong cognitive tracking to examine the corpus callosum. Using spectral confocal reflectance microscopy and transmission electron microscopy, investigators discovered that individuals experiencing severe cognitive decline showed smaller, degenerating axons paired with thicker, decompacted myelin sheaths. These structural anomalies correlate directly with the rate of cognitive deterioration rather than baseline intelligence measured earlier in life, according to the findings.
Did you know? Nearly all participants in the cohort tracking follow-up testing past age 70 demonstrated some level of cognitive decline, giving researchers a clear baseline to compare faster-declining brains with slower-declining ones.
The Role of NRF2 Protein in Myelin Maintenance
Data showed that human participants with more severe cognitive decline had reduced levels of the protein NRF2 within their oligodendrocytes. NRF2 is primarily responsible for regulating hundreds of genes that protect cells from oxidative stress and maintain normal cellular function. When researchers conditionally deleted the NRF2-encoding gene in the oligodendrocytes of mice, the animals developed comparable alterations, including smaller axons and excess myelin, alongside impaired cognitive performance over time, as reported in the study.
Therapeutic Potential and Drug Repurposing Options
Because the NRF2 pathway is already targeted by existing pharmaceutical agents—such as treatments utilized for multiple sclerosis—the findings raise the possibility of drug repurposing. Previous research has demonstrated that activating NRF2 can improve neurological function in multiple sclerosis patients.
Pro Tip for Researchers
When examining white matter integrity in aging populations, investigators must account for regional brain variations. The Edinburgh study focused heavily on the corpus callosum, highlighting the vulnerability of large-diameter myelinated axons to age-related stress.
Frequently Asked Questions
What are oligodendrocytes?
Oligodendrocytes are specialized glial cells in the central nervous system that produce myelin, the protective insulating sheath surrounding nerve fibers that allows efficient electrical signal transmission.
How does NRF2 affect cognitive decline?
NRF2 regulates cellular antioxidant responses and repair mechanisms. According to the Nature Medicine study, lower levels of NRF2 in oligodendrocytes coincide with unhealthy myelin thickening and axonal degeneration.
Can existing drugs target this brain cell dysfunction?
Yes. Because medications already exist that stimulate the NRF2 pathway for conditions like multiple sclerosis, scientists are exploring whether these treatments could eventually be adapted to protect cognitive function in aging adults.
Stay Informed: Explore our latest coverage on neuroscience research and brain health by subscribing to our weekly updates, or leave a comment below to share your thoughts on these findings.